CLINICAL_TRIALS
trial_result
· 2025-03-20
Clinical Trial Update: Study of Magrolimab Combinations in Participants With Myeloid Malignancies [Phase 2]
Summary
Phase 2 study evaluating magrolimab combinations in participants with myeloid malignancies was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Myeloid Malignancies | Phase 2 | Status: TERMINATED | Results posted: 2025-03-20